Trial Details
COMPLETEDBasic Information
| Clinical ID | c1433 |
|---|---|
| Identifier | NCT00503243 |
| Trial Title | Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Delayed and extended release mesalazine |
Participant Information
| Sponsor | Shire |
|---|---|
| City | Philadelphia |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2003-09-30 |
|---|---|
| Primary Completion Date | 2005-01-17 |
| Completion Date | 2005-01-17 |